ni Ronalyn Seminiano Reonico | January 14, 2021
Binigyan na ng emergency use authorization (EUA) ng Food and Drug Administration (FDA) ang Pfizer-BioNTech COVID-19 vaccine kung kaya maaari na itong magamit sa bansa, ayon kay FDA Director General Eric Domingo.
Pahayag ni Domingo, "After thorough review, the FDA is granting EUA to Pfizer-BioNTech COVID-19. The interim data from the ongoing Phase 3 trial shows the vaccine has an efficacy rate of 95% in the study population and at least 92% among all racial groups. The EUA means the benefits outweigh the known and potential risks.
"This is effective immediately.”
Samantala, nilinaw ni Domingo na ang pagbibigay ng EUA ay hindi rin umano nangangahulugan na maaaring ibenta commercially ang naturang bakuna.
Comments